Search review questions

Quality of life · people with age‐related cataract

Costs · people with age‐related cataract

Positive and active engagement in life —not measured · patients with osteoarthritis

Hospital stay · people undergoing laparoscopic cholecystectomy

Resource use and other costs · Children and adolescents with femoral shaft fractures

Reduction of panic symptoms: Panic Disorder Severity Scale (PDSS) (high=poor, data skewed) PDSS, Scale from: 0 to 28) · participants with panic disorder

Quality of life (such as the SF‐36 Health Survey (Ware 1992) · participants with panic disorder

Safety of rTMS: Frequency of rTMS side effects (values are percentages) self‐reported questionnaire · participants with panic disorder

Adverse events · persons with type 1 diabetes mellitus

Microvascular complications · persons with type 1 diabetes mellitus

Progression of neuropathy · persons with type 1 diabetes mellitus

CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1

CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1

CI: confidence interval · Patients suspected to have visceral leishmaniasis disease 1

Treatment‐related mortality · Participants with PCNSL

Quality of life · Participants with PCNSL

Adverse events · people of any age who have survived any type of torture

Improvement in quality of life— · people of any age who have survived any type of torture

Improvement in participation · people of any age who have survived any type of torture

Improvement in family or social relationships · people of any age who have survived any type of torture

Satisfaction with treatment · people of any age who have survived any type of torture

Clinical global response · patients with schizophrenia

General functioning · patients with schizophrenia

Physical fitness · patients with schizophrenia

Adverse effect · patients with schizophrenia

Completed suicide at the end of active intervention · Post‐secondary undergraduate students

Suicidal ideation at the end of active intervention · Post‐secondary undergraduate students

Attempted suicide at the end of active intervention · Post‐secondary undergraduate students

Proportion of women diagnosed with type 2 diabetes or showing impaired glucose tolerance or impaired fasting glucose after giving birth · women with previous gestational diabetes mellitus

Health‐related quality of life · women with previous gestational diabetes mellitus

Diabetes‐associated morbidity · women with previous gestational diabetes mellitus

Costs or other measures of resource use · women with previous gestational diabetes mellitus

Complete resection ‐ iMRI · high grade glioma

Postoperative BCVA (3 months) (LogMAR) · Patients with keratoconus undergoing corneal grafting

Postoperative functional BCVA achieved (3 months) Functional BCVA = vision of 0.30 LogMAR or better. As at, 3 months post‐graft · Patients with keratoconus undergoing corneal grafting

Postoperative BCVA (3 months) (LogMAR) Measured on LogMar scale where normal vision is 0.00. Each line of a LogMAR chart has 5 letters. Each letter is worth 0.02 on the LogMAR scale. A person with vision one full line (five letters) worse than nor... · Patients with keratoconus undergoing corneal grafting

Postoperative functional BCVA achieved (3 months) Functional BCVA = vision of 0.30 LogMAR or better. As at, 3 months post‐graft · Patients with keratoconus undergoing corneal grafting

Service utilisation ‐ days in hospital ‐ medium to long term ‐ not reported · patients with schizophrenia

Global state ‐ compliance with medication ‐ medium to long term ‐ not reported · patients with schizophrenia

Quality of life/satisfaction with care ‐ for recipients or carers ‐ medium to long term ‐ not reported · patients with schizophrenia

Economic outcomes ‐ costs of care ‐ long term ‐ not reported · patients with schizophrenia

Primary outcome: improvement in symptoms (respiratory distress/dyspnoea) · 23 patients aged two years or older with recurrent respiratory papillomatosis

Primary outcome: improvement in symptoms (voice quality) · 23 patients aged two years or older with recurrent respiratory papillomatosis

Primary outcome: improvement in quality of life · 23 patients aged two years or older with recurrent respiratory papillomatosis

Primary outcome: recurrence‐free interval · 23 patients aged two years or older with recurrent respiratory papillomatosis

Reduction in mortality · 23 patients aged two years or older with recurrent respiratory papillomatosis

Reduction in number and/or frequency of surgical interventions and/or time until first relapse requiring surgery · 23 patients aged two years or older with recurrent respiratory papillomatosis

Reduction in number and/or duration of hospital stay(s) · 23 patients aged two years or older with recurrent respiratory papillomatosis

Activity avoidance or restriction · older people living in the community

Hepatitis B Virus infection ‐ not measured · Persons with HIV infection